Reduction of Trauma-induced Intrusions and Amygdala Hyperreactivity Via Non-invasive Brain Stimulation
COOL
1 other identifier
interventional
120
1 country
1
Brief Summary
The study will focus on the modulation of intrusive memories via functional magnetic resonance imaging (fMRI)-guided repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex (dlPFC) directly after exposure to a traumatic video.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2019
CompletedFirst Submitted
Initial submission to the registry
February 28, 2020
CompletedFirst Posted
Study publicly available on registry
March 27, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2020
CompletedMarch 27, 2020
March 1, 2020
11 months
February 28, 2020
March 25, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Number and quality of intrusive thoughts
Sum and stress ratings of intrusive thoughts measured on three consecutive days after trauma exposure by an online questionnaire.
Three days after trauma exposure
Changes in resting state functional connectivity
Functional connectivity data will be assessed by two 10-minutes resting state fMRI scans before and after three sessions of TMS treatment over the course of three days. The resting state fMRI analysis will focus on changes in functional connectivity between regions-of-interest (ROIs) associated with intrusive memories (prefrontal cortex, amygdala, precuneus, insula, hippocampus, cingulate cortex). Changes in functional connectivity between the first and second fMRI sessions will be computed on the first level and independent t-tests will be used to compare the verum and sham TMS groups.
10-minutes resting state fMRI scans before and after three sessions of TMS treatment
Changes in neural response to an emotion recognition task
Changes between the first and second fMRI session in the blood-oxygen-level-dependent (BOLD) signal in response to happy, fearful and neutral faces as well as houses will be compared between the experimental groups. Analysis will focus on anatomically defined regions-of-interest (ROI) associated with emotion processing (i.e. amygdala, prefrontal cortex, insula, striatal areas). Changes in the neural response and functional connectivity between the first and second fMRI sessions will be computed on the first level and independent t-tests will be used to compare the verum and sham TMS groups. For analyses of fMRI data, standard procedures of the software SPM12 will be used.
15-minutes emotional face matching fMRI task before and after three sessions of TMS treatment
Secondary Outcomes (12)
Changes in executive functioning (One Touch Stockings of Cambridge) and attention (Rapid Visual Information Processing) during iTBS treatment
15-minutes cognitive tasks pre/post first iTBS and pre/post last iTBS treatment
Trauma disclosure
Three days after trauma exposure
Changes in electrodermal responses to the trauma video
5 minutes before and during the trauma video
Respiratory changes in response to the trauma video
5 minutes before and during the trauma video
Heart rate changes in response to the trauma video
5 minutes before and during the trauma video
- +7 more secondary outcomes
Study Arms (2)
Active iTBS
EXPERIMENTALActive stimulation of the dlPFC directly after trauma exposure and on the following two days
Placebo iTBS
PLACEBO COMPARATORSame procedure as in the active stimulation group but with a placebo stimulation imitating the sensation of a real iTBS protocol.
Interventions
Eligibility Criteria
You may qualify if:
- Healthy subjects
You may not qualify if:
- current psychiatric illness
- current psychiatric medication or psychotherapy
- past PTSD diagnosis
- MRI contraindication (e.g. metal in body, claustrophobia)
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Psychiatry, University of Bonn
Bonn, 53105, Germany
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rene Hurlemann, MSc, MD, PhD
University of Oldenburg
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor Rene Hurlemann, M.Sc., M.D., Ph.D.
Study Record Dates
First Submitted
February 28, 2020
First Posted
March 27, 2020
Study Start
July 1, 2019
Primary Completion
May 30, 2020
Study Completion
May 30, 2020
Last Updated
March 27, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share